Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD9 | Q9H8M2 | 2/20 | 0.41 |
| ▸ | BRD7 | Q9NPI1 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | METAP2 | P50579 | 1/20 | 0.36 |
| ▸ | ERN1 | O75460 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.34 |
| ▸ | PLAU | P00749 | 1/20 | 0.34 |
| ▸ | PDCD1LG2 | Q9BQ51 | 6/20 | 0.33 |
| ▸ | CD274 | Q9NZQ7 | 6/20 | 0.33 |
| ▸ | BTK | Q06187 | 1/20 | 0.33 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.33 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.33 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22402292 | 0.87 | GABRA1 (0.44) | BRD9BRD7POLBTDP1CYP1A2 | |
| SCHEMBL17826973 | 0.80 | CCR1 (0.48) | BRD9BRD7POLBTDP1CYP1A2 | |
| SCHEMBL17276010 | 0.74 | BRD9 (0.56) | BRD9BRD7POLBTDP1CYP1A2 | |
| SCHEMBL31438401 | 0.74 | BRD9 (0.56) | BRD9BRD7POLBTDP1CYP1A2 | |
| SCHEMBL18287242 | 0.74 | TDP1 (0.45) | BRD9BRD7POLBTDP1ERN1 | |
| SCHEMBL8514010 | 0.73 | SMN1; SMN2 (0.50) | BRD9BRD7POLBTDP1CYP1A2 | |
| SCHEMBL18287252 | 0.72 | CYP1A2 (0.44) | BRD9BRD7CYP1A2METAP2ERN1 | |
| SCHEMBL9906400 | 0.68 | POLB (0.47) | BRD9BRD7POLBTDP1CYP1A2 | |
| SCHEMBL13273322 | 0.67 | BRD9 (0.40) | BRD9BRD7POLBTDP1CYP1A2 | |
| SCHEMBL9007610 | 0.67 | IDH1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8187729-B2 | Organic electroluminescence device | FUJIFILM CORPORATION (JP) | 2012-05-29 | — | — | US | disclosed |
| US-8187729-B2 | Organic electroluminescence device | FUJIFILM CORPORATION (JP) | 2012-05-29 | — | — | US | disclosed |
| US-20090072726-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2009-03-19 | — | — | US | disclosed |
| US-20090072726-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2009-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090072726-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | CLCN2, OR10J3, PUF60 | BRD9 505/4885BRD7 1022/4885POLB 628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.